Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
In clinical trials for tirzepatide, the most common side effects involved mild to moderate gastrointestinal problems
The primary outcomes assessed were resolution of steatohepatitis without worsening fibrosis, and fibrosis improvement without worsening steatohepatitis
Wegovy is a prescription medication designed for weight management in adults with obesity (BMI of 30 or greater) or those who are overweight (BMI of 27 or greater) with at least one weight-related health condition, such as hypertension or type 2 diabetes
The standard pharmacokinetic rule is 4-5 half-lives for steady state
doi:10.1002/ncp.10924 Cardoso, Brbara R et al
US$ 24.93
US$ 29.32
US$ 22.23
US$ 22.35
US$ 22.50
US$ 24.39
US$ 25.52
